Tamsulosin Pellets-Suitable for filling in 0.4mg & 0.8mg Capsules
- Release pattern compared with innovator Flomax.
- MKPPL objective is to develop Tamsulosin hydrochloride SR pellets by aqueous phase and pellets developed by aqueous technology had better advantage of avoiding the use of organic solvents.
- In case of fluid bed coater, to achieve the desired sustained release profile equivalent to innovator, MKPPL drug loaded pellets will be coated with polymers, either single polymer or in combination with different ratios.
- In case of extrusion Spheronization, Tamsulosin hydrochloride SR pellets can be develop by preparing wet mass of API & Excipients.
- Offer complete technical package for registrations in all regulated/semi regulated markets.
Share
Additional information
| Percentage | 0.125%, .13%, .16%, .20% |
|---|---|
| Release Type | Extended Release |
| Target Formulations | Capsules |
| Documentation Available: | DMF in CTD Format |
| Quality Standard | USP43 |
| Forms of PFI | Pellets/Micro pellets (for capsules) |
